312 related articles for article (PubMed ID: 31700973)
1. Skin disease related to metabolic syndrome in women.
Misitzis A; Cunha PR; Kroumpouzos G
Int J Womens Dermatol; 2019 Sep; 5(4):205-212. PubMed ID: 31700973
[TBL] [Abstract][Full Text] [Related]
2. Gynecologic and andrologic dermatology and the metabolic syndrome.
Roth MM; Leader N; Kroumpouzos G
Clin Dermatol; 2018; 36(1):72-80. PubMed ID: 29241756
[TBL] [Abstract][Full Text] [Related]
3. [Cutaneous manifestations of metabolic syndrome].
Holzer G; Straßegger B; Volc-Platzer B
Hautarzt; 2016 Dec; 67(12):982-988. PubMed ID: 27815622
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
Housman E; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
8. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Syndrome and Skin Diseases.
Hu Y; Zhu Y; Lian N; Chen M; Bartke A; Yuan R
Front Endocrinol (Lausanne); 2019; 10():788. PubMed ID: 31824416
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
Elkind-Hirsch KE
Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
[TBL] [Abstract][Full Text] [Related]
11. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.
Wijeyaratne CN; Seneviratne Rde A; Dahanayake S; Kumarapeli V; Palipane E; Kuruppu N; Yapa C; Seneviratne Rde A; Balen AH
Hum Reprod; 2011 Jan; 26(1):202-13. PubMed ID: 21098627
[TBL] [Abstract][Full Text] [Related]
12. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients.
Stefanadi EC; Dimitrakakis G; Antoniou CK; Challoumas D; Punjabi N; Dimitrakaki IA; Punjabi S; Stefanadis CI
Diabetol Metab Syndr; 2018; 10():9. PubMed ID: 29483947
[TBL] [Abstract][Full Text] [Related]
14. Genetics and the metabolic syndrome.
Fanning E; O'Shea D
Clin Dermatol; 2018; 36(1):9-13. PubMed ID: 29241759
[TBL] [Abstract][Full Text] [Related]
15. Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome.
Ni RM; Mo Y; Chen X; Zhong J; Liu W; Yang D
Eur J Endocrinol; 2009 Sep; 161(3):411-8. PubMed ID: 19542239
[TBL] [Abstract][Full Text] [Related]
16. Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study.
Maggio M; Lauretani F; Ceda GP; Bandinelli S; Basaria S; Paolisso G; Ble A; Egan JM; Metter EJ; Abbatecola AM; Zuliani G; Ruggiero C; Valenti G; Guralnik JM; Ferrucci L
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E353-8. PubMed ID: 16968811
[TBL] [Abstract][Full Text] [Related]
17. Acanthosis nigricans, insulin resistance and cutaneous virilism.
Barth JH; Ng LL; Wojnarowska F; Dawber RP
Br J Dermatol; 1988 May; 118(5):613-9. PubMed ID: 3293647
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestations of obesity and themetabolic syndrome.
Uzuncakmak TK; Akdeniz N; Karadag AS
Clin Dermatol; 2018; 36(1):81-88. PubMed ID: 29241757
[TBL] [Abstract][Full Text] [Related]
19. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease.
Regitz-Zagrosek V; Lehmkuhl E; Mahmoodzadeh S
Gend Med; 2007; 4 Suppl B():S162-77. PubMed ID: 18156101
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome: a dermatologic approach.
Moura HH; Costa DL; Bagatin E; Sodré CT; Manela-Azulay M
An Bras Dermatol; 2011; 86(1):111-9. PubMed ID: 21437531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
